SCHEMBL7737137

SCHEMBL7737137

O=C([O-])OO.O=C([O-])OO.O=C([O-])OO.[Sm+3]

nearest known ligand 0.36

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CA4 P22748 3/20 0.36
CA1 P00915 2/20 0.36
FAHD1 Q6P587 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9492690 0.91 CA4 (0.36) CA4CA1FAHD1
SCHEMBL147956 0.91 CA4 (0.36) CA4CA1FAHD1
SCHEMBL8747818 0.91 CA4 (0.36) CA4CA1FAHD1
SCHEMBL6679408 0.91 CA4 (0.36) CA4CA1FAHD1
SCHEMBL23592 0.91 CA4 (0.36) CA4CA1FAHD1
SCHEMBL123336 0.91 CA4 (0.36) CA4CA1FAHD1
SCHEMBL1445922 0.91 CA4 (0.36) CA4CA1FAHD1
SCHEMBL22782 0.91
SCHEMBL8619595 0.91 CA4 (0.36) CA4CA1FAHD1
SCHEMBL9838508 0.91 CA4 (0.36) CA4CA1FAHD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116695184-A Process for preparing rare earth metals 包头稀土研究院 2023-09-05 CN claimed
CN-116409808-A Samarium hydroxide nanorod-based hydrophobic film and preparation process thereof 上海市地江建筑科技有限公司 2023-07-11 CN claimed
CN-109930194-B Sm (OH) CO (carbon monoxide) hydroxyl-based samarium carbonate grown at high temperature and high pressure3Method for single crystal 中国科学院地球化学研究所 2020-02-28 CN claimed
CN-109930194-A Hydroxy carbonate samarium Sm (OH) CO is grown under a kind of high temperature and pressure3The method of monocrystalline 中国科学院地球化学研究所 2019-06-25 CN claimed
US-6419735-B1 YELLOW; CRYSTAL STRUCTURE RHODIA CHIMIE (FR) 2002-07-16 US claimed
CN-116695184-A Process for preparing rare earth metals 包头稀土研究院 2023-09-05 CN disclosed
CN-116409808-A Samarium hydroxide nanorod-based hydrophobic film and preparation process thereof 上海市地江建筑科技有限公司 2023-07-11 CN disclosed
CN-116409808-A Samarium hydroxide nanorod-based hydrophobic film and preparation process thereof 上海市地江建筑科技有限公司 2023-07-11 CN disclosed
US-10918746-B2 Radioactive compositions and methods for their therapeutic use ISOTHERAPEUTICS GROUP LLC (US) 2021-02-16 US disclosed
US-20200155716-A1 RADIOACTIVE COMPOSITIONS AND METHODS FOR THEIR THERAPEUTIC USE ISOTHERAPEUTICS GROUP LLC (US) 2020-05-21 US disclosed
US-10583211-B2 Radioactive compositions and methods for their therapeutic use ISOTHERAPEUTICS GROUP LLC (US) 2020-03-10 US disclosed
CN-109930194-B Sm (OH) CO (carbon monoxide) hydroxyl-based samarium carbonate grown at high temperature and high pressure3Method for single crystal 中国科学院地球化学研究所 2020-02-28 CN disclosed
US-20170258949-A1 RADIOACTIVE COMPOSITIONS AND METHODS FOR THEIR THERAPEUTIC USE ISOTHERAPEUTICS GROUP LLC (US) 2017-09-14 US disclosed
US-9687574-B2 Radioactive compositions and methods for their therapeutic use ISOTHERAPEUTICS GROUP LLC (US) 2017-06-27 US disclosed
US-20150023869-A1 RADIOACTIVE COMPOSITIONS AND METHODS FOR THEIR THERAPEUTIC USE ISOTHERAPEUTICS GROUP LLC (US) 2015-01-22 US disclosed
EP-2793955-A2 RADIOACTIVE COMPOSITIONS AND METHODS FOR THEIR THERAPEUTIC USE ISO Therapeutics Group LLC (US) 2014-10-29 EP disclosed
WO-2013096776-A2 RADIOACTIVE COMPOSITIONS AND METHODS FOR THEIR THERAPEUTIC USE ISO THERAPEUTICS GROUP LLC (US) 2013-06-27 WO disclosed
US-6419735-B1 YELLOW; CRYSTAL STRUCTURE RHODIA CHIMIE (FR) 2002-07-16 US disclosed
US-5015452-A Forced hydrolysis CLARKSON UNIVERSITY (US) 1991-05-14 US disclosed
WO-1988003910-A1 PROCESS FOR SYNTHESIS OF UNIFORM COLLOIDAL PARTICLES OF RARE EARTH OXIDES CLARKSON UNIVERSITY (US) 1988-06-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150023869-A1 RADIOACTIVE COMPOSITIONS AND METHODS FOR THEIR THERAPEUTIC USE SLC39A3, RO60, TP53 CA4 272/4885CA1 178/4885FAHD1 802/4885
US-10583211-B2 Radioactive compositions and methods for their therapeutic use SLC39A3, RO60, TP53 CA4 272/4885CA1 178/4885FAHD1 802/4885
US-20170258949-A1 RADIOACTIVE COMPOSITIONS AND METHODS FOR THEIR THERAPEUTIC USE SLC39A3, RO60, TP53 CA4 272/4885CA1 178/4885FAHD1 802/4885
US-10918746-B2 Radioactive compositions and methods for their therapeutic use SLC39A3, RO60, TP53 CA4 272/4885CA1 178/4885FAHD1 802/4885
US-20200155716-A1 RADIOACTIVE COMPOSITIONS AND METHODS FOR THEIR THERAPEUTIC USE SLC39A3, RO60, TP53 CA4 272/4885CA1 178/4885FAHD1 802/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.